pharma · HIV Infections · Infection, Human Immunodeficiency Virus
ViiV Healthcare
ViiV Healthcare B.V.
ViiV Healthcare is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include HIV Infections, Infection, Human Immunodeficiency Virus. NovaPharmaNews links 3 clinical program(s), 0 drug pr
London, GB HQ
2009 Founded
1,906 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- London, GB
- Founded
- 2009
- Employees
- 1,906
- Programs
- 3
- Drugs
- 5
- Patents
- 0
Dolutegravir/abacavir/lamivudine FDC
Phase 3 · small molecule · Infection, Human Immunodeficiency Virus
Dolutegravir/abacavir/lamivudine FDC for Infection, Human Immunodeficiency Virus is a Phase 3 program (small_molecule) at ViiV Healthcare B.V. with 1 ClinicalTrials.gov record(s).
Internal code 117172
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ViiV Healthcare B.V.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Infection, Human Immunodeficiency Virus
- Status
- completed
- Trials
- 1